Press Releases | DEA.gov
Pasar al contenido principal
U.S. flag

Un sitio oficial del Gobierno de Estados Unidos

Así es como usted puede verificarlo

Dot gov
Los sitios web oficiales usan .gov
Un sitio web .gov pertenece a una organización oficial del Gobierno de Estados Unidos.
Https

Los sitios web seguros .gov usan HTTPS
Un candado ( Candado Un candado cerrado ) o https:// significa que usted se conectó de forma segura a un sitio web .gov. Comparta información sensible sólo en sitios web oficiales y seguros.

  • Quiénes somos
    • Sobre la DEA
    • Mission
    • Leadership
    • Nuestra historia
    • Divisiones Nacionales
      • Operational Divisions
    • DEA Museum
    • Wall of Honor
    • Contáctenos
      • Submit a Tip
      • Extortion Scam
      • Public Affairs
      • Social Media Directory
  • Recursos
    • Cartels
    • Illegal Online Pharmacies
    • OD Justice
    • Fentanyl Supply Chain
    • Pill Press Resources
    • Recovery Resources
    • Together for Families
    • Ley de Libertad de Información
      • Fee Waiver
    • Publications
    • Galerías Multimedia
    • Programa de Asistencia a Testigos para Víctimas
      • Human Trafficking Prevention

United States Drug Enforcement Administration

  • Recibir Actualizaciones
  • Scam Alert
  • Menú Completo
  • English
  • Español

Main Menu

Explore DEA
  • Quiénes somos
    • Sobre la DEA
    • Mission
    • Leadership
    • Nuestra historia
    • Divisiones Nacionales
    • DEA Museum
    • Wall of Honor
    • Contáctenos
  • Recursos
    • Cartels
    • Illegal Online Pharmacies
    • OD Justice
    • Fentanyl Supply Chain
    • Pill Press Resources
    • Recovery Resources
    • Together for Families
    • Ley de Libertad de Información
    • Publications
    • Galerías Multimedia
    • Programa de Asistencia a Testigos para Víctimas

Press Releases

Advanced Search

Enter Keywords Below

Filter Results

Select To Narrow Search Results

Year

  • 2025 (38)
  • 2024 (43)
  • 2023 (76)
  • 2022 (77)
  • 2021 (44)
  • 2020 (8)
  • 2019 (2)
  • 2017 (1)
  • 2016 (1)

Subject

  • Drug Trafficking (4013)
  • Synthetic drugs (1065)
  • Guns/Weapons (990)
  • OCDETF/Task Force (810)
  • Fake Pills (655)
  • Arrests/Convictions - Major (604)
  • Guilty Plea (530)
  • Seizures (Drugs/Property) (457)
  • Prescription Drugs (364)
  • Overdose (321)
  • Major Law Enforcement Operation (268)
  • Take Back Day (246)
  • Task Forces/Task Force Officers (231)
  • Pharmaceuticals/Pharmacists/Physicians (224)
  • Money Laundering (203)
  • Gangs (196)
  • Outreach/Drug Prevention (184)
  • Fentanyl Awareness (152)
  • One Pill Can Kill (110)
  • HIDTA (103)
  • Press Conferences (68)
  • Narcoterrorism (53)
  • Prevention/Education - DEA websites GSAD, JTT etc (53)
  • Extraditions (50)
  • Dark Web- Internet Trafficking (29)
  • Asset Forfeiture (28)
  • International/Foreign Operations (28)
  • Red Ribbon (27)
  • Congressional Affairs (15)
  • Terrorism (14)
  • Fentanyl Free America (12)
  • Intergovernmental Affairs (9)
  • Campaigns (8)
  • Other (8)
  • Counterfeit Pills (6)
  • Critical Incident (6)
  • Intelligence Division - Intelligence Products (5)
  • Scam Calls (5)
  • Museum and Visitors Center (3)
  • El Paso Intelligence Center (2)
  • Recruitment/Office of Training/Graduations (2)
  • Diversion Division (242)
  • Public and Media Affairs - also see Congressional Affairs (50)

Drug Name

  • Opioids (44)
  • Fentanyl (38)
  • Oxycodone (38)
  • Hydromorphone (13)
  • Synthetic Opioids (12)
  • Methamphetamine (11)
  • Benzodiazepines (7)
  • Morphine (6)
  • Amphetamines (3)
  • Cocaine (3)
  • Methadone (3)
  • Steroids (3)
  • Heroin (2)
  • Marijuana (Cannabis) (2)
  • Ketamine (1)
  • Marijuana Concentrates (1)

Field Division

  • Washington, DC (42)
  • New England (33)
  • New York (26)
  • Sede (25)
  • Seattle (22)
  • Chicago (18)
  • New Jersey (17)
  • Houston (15)
  • Atlanta (13)
  • New Orleans (11)
  • El Paso (10)
  • Miami (10)
  • Omaha (8)
  • San Francisco (7)
  • St. Louis (7)
  • Rocky Mountain (6)
  • Dallas (5)
  • Los Angeles (3)
  • Phoenix (3)
  • San Diego (3)
  • Detroit (2)
  • Louisville (2)
  • Caribe (1)
  • Philadelphia (1)
Clear All Results
PRESS RELEASE

Major Rewards Offered for Capture and Conviction of Leaders of Honduran Drug Trafficking Operation

Mayo 02, 2022
ALEXANDRIA, Va. – Today the U.S. Department of State and the DEA's Washington Division announced a reward of up to $5 million each for information leading to the arrest and conviction of three Honduran nationals indicted in the Eastern District of Virginia on charges stemming from their roles as leading...
Mayo 02, 2022
PRESS RELEASE

Wisconsin Pharmacy to Pay Civil Penalty for Controlled Substance Dispensing and Record Keeping Violations

Abril 29, 2022
MADISON, Wis. – John G. McGarry, Assistant Special Agent in Charge of Drug Enforcement Administration-Wisconsin, and U.S. Attorney Timothy M. O’Shea, of the Western District of Wisconsin, announced today that Cadott Miller Pharmacy, Ltd., located in Cadott, Wisconsin, entered into a settlement agreement to pay $20,000 to resolve civil allegations...
Abril 29, 2022
PRESS RELEASE

Drug Enforcement Administration Reaches Settlement in Class Action Lawsuit

Abril 29, 2022
WASHINGTON – The Drug Enforcement Administration (DEA) announced today that it has reached an agreement in principle to settle Garcia, et al. v. Merrick Garland, Attorney General, Dep’t of Justice, a class action lawsuit brought on behalf of female Special Agents who were not selected for overseas assignments between 1990...
Abril 29, 2022
PRESS RELEASE

DEA Chicago Suspends Registration of Suburban Chicago Pharmacy

Abril 28, 2022
CHICAGO – Robert Bell, Special Agent in Charge of the U.S. Drug Enforcement Administration - Chicago Division, announced that on April 27, 2022, DEA Chicago Diversion Investigators delivered an Immediate Suspension Order to Evergreen Park Pharmacy, located at 2850 W. 95th Street, Suite 100, Evergreen Park, Illinois, suspending its DEA...
Abril 28, 2022
PRESS RELEASE

Richland Physician Sentenced for Conspiring to Distribute Medically Unnecessary Fentanyl Patches, Opioid Pills and Other Controlled Substances

Abril 28, 2022
SPOKANE, Wash. – Senior U.S. District Judge Edward F. Shea has sentenced Dr. Janet Sue Arnold, age 63, of Benton City, Washington, to 48 months in federal prison for conspiring to distribute and possess with intent to distribute opioid pain medications and other controlled substances without a legitimate medical purpose...
Abril 28, 2022
PRESS RELEASE

Two Naturopaths Agree to Pay $32,000 in Civil Penalties For Improper Prescription of Opioids and Controlled Substances

Abril 25, 2022
SPOKANE, Wash.– Dr. Jacqueline Thomas, N.D., an East Wenatchee-based naturopathic doctor, and Dr. Rebecka Hoppins, an Edmonds-based naturopathic doctor, have each agreed to pay $16,500 to resolve allegations under the Controlled Substances Act that they improperly prescribed controlled substances. The Controlled Substances Act regulates certain drugs deemed to pose a...
Abril 25, 2022
PRESS RELEASE

Former El Paso Physician Agrees to Pay $350,000 to Resolve Allegations

Abril 25, 2022
EL PASO, Texas – Dr. Herbert Nassour, a former physician in El Paso, has agreed to pay $350,000 under a civil settlement to resolve allegations he violated certain provisions of the Controlled Substances Act (CSA). Dr. Nassour was a physician registered with the Drug Enforcement Administration (DEA) to prescribe and...
Abril 25, 2022
PRESS RELEASE

DEA Holds 22nd National Prescription Drug Take Back Day to prevent addiction and reduce overdose deaths

Abril 15, 2022
EL PASO – The Drug Enforcement Administration will host its 22nd National Prescription Drug Take Back Day on Saturday, April 30 from 10 a.m. to 2 p.m. This bi-annual event offers free, anonymous disposal of unneeded medications at more than 4,000 local drop-off locations nationwide. “Disposing of unneeded medications can...
Abril 15, 2022
PRESS RELEASE

Prisma Health Midlands to Pay $1 Million to Resolve Alleged Controlled Substance Act Violations

Abril 05, 2022
COLUMBIA, SOUTH CAROLINA — Prisma Health Midlands (“Prisma”) has agreed to pay a record $1 million to resolve allegations that it committed recordkeeping and dispensing violations of the Controlled Substances Act (CSA). These requirements are designed to prevent the diversion of controlled substances. This civil settlement includes a memorandum of...
Abril 05, 2022
PRESS RELEASE

DEA’s Commitment to Expanding Access to Medication-Assisted Treatment

Marzo 23, 2022
WASHINGTON – Today, Administrator Anne Milgram announced the Drug Enforcement Administration’s continued commitment to expanding access to medication-assisted treatment to help those suffering from substance use disorder. “In this moment, when the United States is suffering tens of thousands of opioid-related overdose deaths every year, the DEA’s top priority is...
Marzo 23, 2022
Showing 201 - 210 of 290 results

Paginación

  • Primera página «
  • Página anterior ‹
  • Página 17
  • Página 18
  • Página 19
  • Página 20
  • Current page 21
  • Página 22
  • Página 23
  • Página 24
  • Página 25
  • Siguiente página ›
  • Última página »
  • Quienes Somos
    • Sobre
    • Contáctenos
    • Museo DEA
  • Recursos
    • Ley de Libertad de Información (FOIA)
    • Publicaciones
    • Galerías Multimedia
    • Programa de Asistencia a Testigos para Víctimas
  • Políticas
    • Accesibilidad, Complementos y Política
    • Políticas Legales y Descargos de Responsabilidad
    • Antidiscriminación y Represalias Acto
    • Política de Privacidad
    • Política de Igualdad de Oportunidades en el Empleo del U.S. DOJ
    • USA.gov
    • Protección de Denunciantes
    • Your Rights as a Federal Employee

United States Drug Enforcement Administration

DEA.gov is an official site of the U.S. Department of Justice
Facebook X LinkedIn Instagram

DEA Contact Center

(202) 307-1000 info@dea.gov
Contact the Webmaster